Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine reversal of atracurium during thyroid surgery
ACTRN12611000914965Phase 4Completed
- Sponsor
- Aptamer Group
- Start
- Aug 2011
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, double-blind trial of neostigmine, glycopyrronium and atracurium in thyroid disease, sponsored by Aptamer Group. Started Aug 2011; status: completed.
02
Drugs
neostigmineglycopyrroniumatracurium
03
Conditions
thyroid disease
Beyond the preview
Go deeper on ACTRN12611000914965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000914965.